Effector and memory T cell responses to commensal bacteria

Trends in Immunology

Volumn 34, Issue 6, 2013, Pages 299-306

  Belkaid, Yasmine ^a   Bouladoux, Nicolas ^a   Hand, Timothy W ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN SPECIFICITY; CELL DIFFERENTIATION; COMMENSAL; GASTROINTESTINAL DISEASE; GENETIC PREDISPOSITION; HOMEOSTASIS; IMMUNE RESPONSE; IMMUNE SYSTEM; INFECTION; INFLAMMATION; MEMORY T LYMPHOCYTE; MICROFLORA; NONHUMAN; REGULATORY MECHANISM; REVIEW; STEADY STATE; ULCERATIVE COLITIS;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIA; HUMANS; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; IMMUNOLOGIC MEMORY; INFECTION; INTESTINES; MICROBIOTA; SYMBIOSIS; T-LYMPHOCYTES;

EID: 84878597238     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2013.03.003     Document Type: Review

References (122)

1. Foulongne V., et al. Human skin microbiota: high diversity of DNA viruses identified on the human skin by high throughput sequencing. PLoS ONE 2012, 7:e38499.
2. Iliev I.D., et al. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science 2012, 336:1314-1317.
3. Reyes A., et al. Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature 2010, 466:334-338.
4. Eckburg P.B., et al. Archaea and their potential role in human disease. Infect. Immun. 2003, 71:591-596.
5. Grice E.A., Segre J.A. The human microbiome: our second genome. Annu. Rev. Genomics Hum. Genet. 2012, 13:151-170.
6. Ley R.E., et al. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006, 124:837-848.
7. Clemente J.C., et al. The impact of the gut microbiota on human health: an integrative view. Cell 2012, 148:1258-1270.
8. Qin J., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.
9. Backhed F., et al. Host-bacterial mutualism in the human intestine. Science 2005, 307:1915-1920.
10. Costello E.K., et al. The application of ecological theory toward an understanding of the human microbiome. Science 2012, 336:1255-1262.
11. Stecher B., Hardt W.D. Mechanisms controlling pathogen colonization of the gut. Curr. Opin. Microbiol. 2011, 14:82-91.
12. Hooper L.V., et al. Interactions between the microbiota and the immune system. Science 2012, 336:1268-1273.
13. Zhou L., et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008, 453:236-240.
14. Murphy K.M., Stockinger B. Effector T cell plasticity: flexibility in the face of changing circumstances. Nat. Immunol. 2010, 11:674-680.
15. Maynard C.L., Weaver C.T. Intestinal effector T cells in health and disease. Immunity 2009, 31:389-400.
16. Hall J.A., et al. Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity 2008, 29:637-649.
17. Konkel J.E., Chen W. Balancing acts: the role of TGF-beta in the mucosal immune system. Trends Mol. Med. 2011, 17:668-676.
18. Bettelli E., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
19. Hu W., et al. Priming microenvironments dictate cytokine requirements for T helper 17 cell lineage commitment. Immunity 2011, 35:1010-1022.
20. Hall J.A., et al. Essential role for retinoic acid in the promotion of CD4(+) T cell effector responses via retinoic acid receptor alpha. Immunity 2011, 34:435-447.
21. Fossiez F., et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 1996, 183:2593-2603.
22. Korn T., et al. IL-17 and Th17 Cells. Annu. Rev. Immunol. 2009, 27:485-517.
23. Sonnenberg G.F., et al. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat. Immunol. 2011, 12:383-390.
24. Ishigame H., et al. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 2009, 30:108-119.
25. Zheng Y., et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 2008, 14:282-289.
26. Sonnenberg G.F., et al. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 2012, 336:1321-1325.
27. Bilate A.M., Lafaille J.J. Induced CD4+Foxp3+ regulatory T cells in immune tolerance. Annu. Rev. Immunol. 2012, 30:733-758.
28. Coombes J.L., et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-{beta}- and retinoic acid-dependent mechanism. J. Exp. Med. 2007, 204:1757-1764.
29. Sun C.M., et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 2007, 204:1775-1785.
30. Gaboriau-Routhiau V., et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 2009, 31:677-689.
31. Atarashi K., et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011, 331:337-341.
32. Ivanov I.I., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139:485-498.
33. Mazmanian S.K., et al. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008, 453:620-625.
34. Naik S., et al. Compartmentalized control of skin immunity by resident commensals. Science 2012, 337:1115-1119.
35. Mazmanian S.K., et al. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005, 122:107-118.
36. O'Mahony C., et al. Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation. PLoS Pathog. 2008, 4:e1000112.
37. Ochoa-Reparaz J., et al. Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. J. Immunol. 2010, 185:4101-4108.
38. Round J.L., et al. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 2011, 332:974-977.
39. Molloy M.J., et al. Intestinal microbiota: shaping local and systemic immune responses. Semin. Immunol. 2012, 24:58-66.
40. Wu H.J., et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010, 32:815-827.
41. Abt M.C., et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 2012, 37:158-170.
42. Ichinohe T., et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:5354-5359.
43. Brandl K., et al. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 2008, 455:804-807.
44. Vaishnava S., et al. The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science 2011, 334:255-258.
45. Cong Y., et al. A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:19256-19261.
46. Macpherson A.J., et al. The mucosal firewalls against commensal intestinal microbes. Semin. Immunopathol. 2009, 31:145-149.
47. Macpherson A.J., Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004, 303:1662-1665.
48. Weiner H.L., et al. Oral tolerance. Immunol. Rev. 2011, 241:241-259.
49. Mucida D., et al. Retinoic acid can directly promote TGF-beta-mediated Foxp3(+) Treg cell conversion of naive T cells. Immunity 2009, 30:471-473.
50. Mucida D., et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007, 317:256-260.
51. Benson M.J., et al. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med. 2007, 204:1765-1774.
52. Denning T.L., et al. Functional specializations of intestinal dendritic cell and macrophage subsets that control Th17 and regulatory T cell responses are dependent on the T cell/APC ratio, source of mouse strain, and regional localization. J. Immunol. 2011, 187:733-747.
53. Mora J.R., et al. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 2006, 314:1157-1160.
54. Round J.L., Mazmanian S.K. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:12204-12209.
55. Lathrop S.K., et al. Peripheral education of the immune system by colonic commensal microbiota. Nature 2011, 478:250-254.
56. Feng T., et al. Interleukin-12 converts Foxp3+ regulatory T cells to interferon-gamma-producing Foxp3+ T cells that inhibit colitis. Gastroenterology 2011, 140:2031-2043.
57. Tsuji M., et al. Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer's patches. Science 2009, 323:1488-1492.
58. Suzuki K., et al. Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:1981-1986.
59. Peterson D.A., et al. IgA response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host Microbe 2007, 2:328-339.
60. Lochner M., et al. Restricted microbiota and absence of cognate TCR antigen leads to an unbalanced generation of Th17 cells. J. Immunol. 2011, 186:1531-1537.
61. Geuking M.B., et al. Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity 2011, 34:794-806.
62. Ivanov I.I., et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008, 4:337-349.
63. Hill D.A., et al. Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal Immunol. 2010, 3:148-158.
64. Lozupone C.A., et al. Diversity, stability and resilience of the human gut microbiota. Nature 2012, 489:220-230.
65. Dethlefsen L., Relman D.A. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc. Natl. Acad. Sci. U.S.A. 2011, 108(Suppl. 1):4554-4561.
66. Chow J., et al. Pathobionts of the gastrointestinal microbiota and inflammatory disease. Curr. Opin. Immunol. 2011, 23:473-480.
67. Rolhion N., Darfeuille-Michaud A. Adherent-invasive Escherichia coli in inflammatory bowel disease. Inflamm. Bowel Dis. 2007, 13:1277-1283.
68. Qin J., et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012, 490:55-60.
69. Arthur J.C., et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012, 338:120-123.
70. Heimesaat M.M., et al. Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii. J. Immunol. 2006, 177:8785-8795.
71. Craven M., et al. Inflammation drives dysbiosis and bacterial invasion in murine models of ileal Crohn's disease. PLoS ONE 2012, 7:e41594.
72. Garrett W.S., et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 2010, 8:292-300.
73. Lupp C., et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2007, 2:119-129.
74. Egan C.E., et al. Synergy between intraepithelial lymphocytes and lamina propria T cells drives intestinal inflammation during infection. Mucosal Immunol. 2011, 4:658-670.
75. Benson A., et al. Gut commensal bacteria direct a protective immune response against Toxoplasma gondii. Cell Host Microbe 2009, 6:187-196.
76. Ubeda C., et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J. Clin. Invest. 2010, 120:4332-4341.
77. Britton R.A., Young V.B. Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance. Trends Microbiol. 2012, 20:313-319.
78. Slack E., et al. Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 2009, 325:617-620.
79. Hand T.W., et al. Acute gastrointestinal infection induces long-lived microbiota-specific T cell responses. Science 2012, 337:1553-1556.
80. Wong F. Recent advances in our understanding of hepatorenal syndrome. Nat. Rev. Gastroenterol. Hepatol. 2012, 9:382-391.
81. Nieman D.C., et al. Ibuprofen use, endotoxemia, inflammation, and plasma cytokines during ultramarathon competition. Brain Behav. Immun. 2006, 20:578-584.
82. Zimmermann K., et al. Systemic antibody responses to gut microbes in health and disease. Gut Microbes 2012, 3:42-47.
83. Purohit V., et al. Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium. Alcohol 2008, 42:349-361.
84. Arakawa T., et al. Small intestinal injury caused by NSAIDs/aspirin: finding new from old. Curr. Med. Chem. 2012, 19:77-81.
85. Hughes S.M., et al. Dendritic cell anergy results from endotoxemia in severe malnutrition. J. Immunol. 2009, 183:2818-2826.
86. Berkley J.A., et al. Bacteremia among children admitted to a rural hospital in Kenya. N. Engl. J. Med. 2005, 352:39-47.
87. Meinzer U., et al. Yersinia pseudotuberculosis effector YopJ subverts the Nod2/RICK/TAK1 pathway and activates caspase-1 to induce intestinal barrier dysfunction. Cell Host Microbe 2012, 11:337-351.
88. Brenchley J.M., et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 2006, 12:1365-1371.
89. Brenchley J.M., Douek D.C. Microbial translocation across the GI tract. Annu. Rev. Immunol. 2012, 30:149-173.
90. Estes J.D., et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog. 2010, 6:e1001052.
91. Vernacchio L., et al. Diarrhea in American infants and young children in the community setting: incidence, clinical presentation and microbiology. Pediatr. Infect. Dis. J. 2006, 25:2-7.
92. Kosek M., et al. The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull. World Health Organ. 2003, 81:197-204.
93. Oldenhove G., et al. Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 2009, 31:772-786.
94. Severance E.G., et al. Anti-gluten immune response following Toxoplasma gondii infection in mice. PLoS ONE 2012, 7:e50991.
95. Lodes M.J., et al. Bacterial flagellin is a dominant antigen in Crohn disease. J. Clin. Invest. 2004, 113:1296-1306.
96. Pepper M., et al. Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells. Nat. Immunol. 2009, 11:83-89.
97. Homann D., et al. Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory. Nat. Med. 2001, 7:913-919.
98. Hapfelmeier S., et al. Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science 2010, 328:1705-1709.
99. Geddes K., et al. Identification of an innate T helper type 17 response to intestinal bacterial pathogens. Nat. Med. 2011, 17:837-844.
100. Su L.F., et al. Virus-specific CD4(+) memory-phenotype T cells are abundant in unexposed adults. Immunity 2013, 38:373-383.
101. Sartor R.B. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 2006, 3:390-407.
102. Kaser A., et al. Inflammatory bowel disease. Annu. Rev. Immunol. 2010, 28:573-621.
103. Maloy K.J., Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011, 474:298-306.
104. Barrett J.C., et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet. 2008, 40:955-962.
105. Franke A., et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat. Genet. 2010, 42:1118-1125.
106. McGovern D.P., et al. Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat. Genet. 2010, 42:332-337.
107. Anderson C.A., et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat. Genet. 2011, 43:246-252.
108. Jostins L., et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012, 491:119-124.
109. Kim S.C., et al. Dual-association of gnotobiotic IL-10-/- mice with 2 nonpathogenic commensal bacteria induces aggressive pancolitis. Inflamm. Bowel Dis. 2007, 13:1457-1466.
110. Kullberg M.C., et al. Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis. J. Exp. Med. 2002, 196:505-515.
111. Yoshida M., et al. Differential localization of colitogenic Th1 and Th2 cells monospecific to a microflora-associated antigen in mice. Gastroenterology 2002, 123:1949-1961.
112. Cong Y., et al. CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease. J. Exp. Med. 1998, 187:855-864.
113. Watanabe T., et al. Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis. Immunity 2006, 25:473-485.
114. Feng T., et al. Microbiota innate stimulation is a prerequisite for T cell spontaneous proliferation and induction of experimental colitis. J. Exp. Med. 2010, 207:1321-1332.
115. Devkota S., et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature 2012, 487:104-108.
116. Kullberg M.C., et al. Induction of colitis by a CD4+ T cell clone specific for a bacterial epitope. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:15830-15835.
117. Kullberg M.C., et al. Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation. Infect. Immun. 2001, 69:4232-4241.
118. Powrie F., Uhlig H. Animal models of intestinal inflammation: clues to the pathogenesis of inflammatory bowel disease. Novartis Found. Symp. 2004, 263:164-174.
119. Bloom S.M., et al. Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe 2011, 9:390-403.
120. Iskandar H.N., Ciorba M.A. Biomarkers in inflammatory bowel disease: current practices and recent advances. Transl. Res. 2012, 159:313-325.
121. Haas A., et al. Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection. Gut 2011, 60:1506-1519.
122. Cadwell K., et al. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 2010, 141:1135-1145.